Efficacy and Safety of Upadacitinib in Giant Cell Arteritis

This chapter explores the findings of Abstract 0770 from ACR 2024, revealing the effectiveness of upadacitinib over placebo in treating giant cell arteritis, with notable improvements in sustained remission and reduced steroid use. It also addresses the safety concerns of Janus kinase inhibitors and discusses the complexities surrounding CAR T therapy in autoimmune diseases.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app